Pharmaceutical Account Management Models Must Adapt to Payer-Driven Healthcare Landscape

Guidehouse argues that pharmaceutical key account management remains fundamentally a rebranded sales function rather than a true value-based engagement model, even as the customer base has shifted toward payers, government programs, and integrated delivery systems. The piece describes how pharma companies continue measuring account managers on traditional sales metrics while healthcare purchasers—including Medicaid programs and managed care organizations—now make formulary and utilization decisions based on population health value rather than individual prescriber relationships. For Medicaid MCOs, this signals ongoing misalignment between pharmaceutical commercial strategies and the outcomes-focused contracting models that managed care plans actually need.

Pharmacy

This is outside commentary from Guidehouse, not part of Medicaid Monitor's independently scored news coverage.

More from Guidehouse